Tweet
Kansas City Star
<img alt="" height="1" width="1" />
Sangamo BioSciences Announces Four Data Presentations at CROI 2011 of Novel ...
PR Newswire (press release)
RICHMOND, Calif., March 3, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the ...
Gene Therapy Against HIV Not a Proven Cure, Experts SayBusinessWeek
Sangamo's Gene Therapy for HIV is Safe, Helps Immune Cells in Early TrialBloomberg
CROI: HIV-Resistant T Cells on HorizonMedPage Today
Reuters -FierceBiotech -Philadelphia Inquirer
all 461 news articles »
More...